Hold Alembic Pharmaceuticals, target price Rs 730: JM Financial
Alembic Pharmaceuticals, incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 11514.67 Crore) operating in Pharmaceuticals sector.
Why Daljeet Singh Kohli continues to put faith in Gland Pharma and Divi’s Lab
“Gland Pharma which after the results, showed 15% decline in one single day. But I think that was more to do with some sentiments on Chinese promoters or something of that kind. Nobody knows the actual reason. In fact, the company has shown a quarter-on-quarter good recovery of almost 20%. ”
Alembic Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Royalty Income and Other Operating Revenue for the year ending 31-Mar-2022.
Stocks in the news: Biocon, NMDC, Brigade Enterprises, PB Fintech, SpiceJet and NDTV
Rajesh Exports, AVG Logistics, Shahlon Silk Industries, MRC Agrotech, Lee & Nee Softwares, Milton Industries and Destiny Logistics & Infra are among the companies that will announce their results for September 2022 quarter today.
Stocks in the news: LIC, Godrej Properties, ONGC, Fortis, Bharat Dynamics and ZEEL
ONGC, Grasim, IRCTC, Bharat Forge, Biocon, Abbott India, Balkrishna Industries, NMDC, Aarti Industries, AIA Engineering, GMR Infra, Godrej Industries and Radico Khaitan are among the companies that will announce their results for September 2022 quarter today.
The company reported Rs 164 crore in net profit in Q2FY22. Revenues dropped 12% YoY to Rs 1475 crore in Q2FY23 compared to Rs 1313 crore last year.The earnings before interest, tax, depreciation and amortization (EBITA) declined 13% YoY to Rs 231 crore. The EBITDA margins stood at 16% in Q2FY23
Mazagon Dock, Alembic Pharma among 30 BSE500 stocks that rallied up to 22% during the week
Global brokerage firm Morgan Stanley upgraded Bank of India to 'overweight' on Friday after the lender reported strong numbers in the July-September quarter. It also raised the price target to Rs 95 a share from Rs 53 earlier.markets/stocks/news
Alembic Pharma jumps over 6% on getting approval from USFDA for Mesalamine extended-release capsules
“The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Apriso Extended-Release Capsules, 0.375 g, of Salix Pharmaceuticals, Inc. (Salix). Mesalamine Extended-Release Capsules are indicated for the maintenance of remission of ulcerative colitis in adults,” the company said in a BSE filing.
Ahead of Market: 10 things that will decide D-Street action on Friday
Nagaraj Shetti, Technical Research Analyst, HDFC Securities, said, “Zooming into the 15-minute chart, we see that the Nifty opened with a down gap, but buying soon emerged from the lows and pushed the index higher. The Nifty thus remains in a short-term uptrend as it has moved above the previous swing highs of 17,429 and made higher bottoms over the last few weeks.”
Ahead of Market: 10 things that will decide D-Street action on Monday
Wall Street stocks fell Friday to conclude a volatile week with markets shrugging off mostly solid bank earnings amid worries over bond yields and rising recession risk. JPMorgan Chase, Citigroup and Wells Fargo all rallied after reporting profits that exceeded analyst expectations even as they highlighted increased economic risks.
Ahead of Market: 10 things that will decide D-St action on Thursday
Nagaraj Shetti, Technical Research Analyst, HDFC Securities, said: “After showing sharp weakness on Tuesday, Nifty shifted into a sustainable upside bounce amidst volatility on Wednesday and closed the day higher by 140 points. Intraday buying emerged from the day's low of 16960 levels, and the market continued its upside momentum till the end.
Ahead of Market: 10 things that will decide D-St action on Thursday
Nagaraj Shetti, Technical Research Analyst, HDFC Securities, said: “After showing sharp weakness on Tuesday, Nifty shifted into a sustainable upside bounce amidst volatility on Wednesday and closed the day higher by 140 points. Intraday buying emerged from the day's low of 16960 levels, and the market continued its upside momentum till the end.
Ahead of Market: 10 things that will decide D-St action on Thursday
Nagaraj Shetti, Technical Research Analyst, HDFC Securities, said: “After showing sharp weakness on Tuesday, Nifty shifted into a sustainable upside bounce amidst volatility on Wednesday and closed the day higher by 140 points. Intraday buying emerged from the day's low of 16960 levels, and the market continued its upside momentum till the end.
These 28 stocks zoom up to 70% in Q2; do you own any?
Last month, ICICIDirect Research initiated coverage on Mazagaon Dock with a buy rating and a target price of Rs 560, whereas Equirus sees Ceat at Rs 3,654 in next three years on the back of rising market shares of the tyre company.
Ahead of Market: 10 things that will decide D-St action on Friday
We expect the market to remain in consolidation mode for the next few days until the US Fed rate action is over. However, intermittent volatility may not be ruled out due to adverse global cues.That said, heres a look at what some key indicators are suggesting for Fridays action
Ahead of Market: 10 things that will decide D-St action on Thursday
Nagaraj Shetti, Technical Research Analyst, HDFC Securities, said after showing a consistent upmove in the last few sessions, Nifty witnessed an excellent upside recovery from the lows on Wednesday and closed the day lower by 66 points
Ahead of Market: 10 things that will decide D-St action on Wednesday
Nagaraj Shetti, Technical Research Analyst, HDFC Securities, said, “The upmove with range-bound action continued in the market on Tuesday, and Nifty closed higher by 133 points amidst lacklustre type movement. After opening with an upside gap, the market moved up in the early hours.
Ahead of Market: 10 things that will decide D-St action on Thursday
Wall Street stocks rose on Wednesday, shaking off recent weakness as markets grappled with the likelihood of additional Federal Reserve interest rate hikes.Analysts warned of more volatility ahead as the Wall Street Journal reported that the Fed appeared likely to enact another 75 basis point interest rate increase
Ahead of Market: 10 things that will decide D-St action on Tuesday
Gas deliveries had been due to resume on Saturday, but Russia scrapped that deadline on Friday and did not give a new timeframe for re-opening. The news stoked fears of a recession in Europe, with businesses and households hurt by sky-high energy prices.
Time for NDTV shareholders to sell in market or give it in open offer: Daljeet Singh Kohli
“Stocks like Siemens, Honeywell Automation, ABB, Hitachi have been on our buying radar since January. We are looking for good returns. In the last four-five years they have not given returns and there will be a lot of capex on the upgradation of machinery. Many of these companies have adopted automation and digitisation. One stock to play auto ancillary plus digitisation is Bosch.”
Ahead of Market: 10 things that will decide D-St action on Wednesday
European markets closed lower Tuesday, with investors digesting a rise in oil prices and fresh economic data out of the eurozone. The pan-European Euro Stoxx 600 provisionally ended down 0.5%The euro also fell to fresh two-decade lows after data showed eurozone business activity contracted for a second straight month in August as the war in Ukraine is expected to ensure the outlook for the European economy remains bleak.
Ahead of Market: 10 things that will decide D-St action on Tuesday
Shares in European tech companies were underperforming the wider market, with the tech index of shares approaching its August low, down 1.7%. Meanwhile the STOXX 600 fell 0.8%. So far this year, European tech shares are down 24% while the wider index has lost 10.3%.
Corporate Radar: Alembic, Manappuram to turn ex-dividend, AGMs, stock split and more
Manappuram Finance (Re 0.75 per share), Container Corporation Of India (Rs 2 per share), Alembic Pharmaceuticals (Rs 10 per share) and Jagran Prakashan (Rs 4 per share) had announced their interim dividends.